In the pursuit of market outperformance, investors navigate the landscape of stock selection. The right picks can play a pivotal role in enhancing your wealth.
The price of Centessa Pharmaceuticals plc ADR (NASDAQ: CNTA) closed at $11.57 in the last session, up 2.66% from day before closing price of $11.27. In other words, the price has increased by $2.66 from its previous closing price. On the day, 0.64 million shares were traded. CNTA stock price reached its highest trading level at $11.72 during the session, while it also had its lowest trading level at $10.87.
Ratios:
We take a closer look at CNTA’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 9.25 and its Current Ratio is at 9.25. In the meantime, Its Debt-to-Equity ratio is 0.29 whereas as Long-Term Debt/Eq ratio is at 0.29.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Piper Sandler on March 31, 2025, initiated with a Overweight rating and assigned the stock a target price of $38.
Morgan Stanley Upgraded its Equal-Weight to Overweight on September 20, 2024, whereas the target price for the stock was revised from $11 to $26.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Mar 25 ’25 when Weinhoff Gregory M sold 10,000 shares for $16.34 per share. The transaction valued at 163,386 led to the insider holds 134,021 shares of the business.
Weinhoff Gregory M bought 10,000 shares of CNTA for $165,300 on Mar 25 ’25. On Mar 20 ’25, another insider, SAHA SAURABH, who serves as the Chief Executive Officer of the company, sold 55,000 shares for $16.69 each. As a result, the insider received 918,060 and left with 276,017 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, CNTA now has a Market Capitalization of 1540938880 and an Enterprise Value of 1176593920.
Stock Price History:
The Beta on a monthly basis for CNTA is 1.61, which has changed by 0.07328391 over the last 52 weeks, in comparison to a change of 0.059571505 over the same period for the S&P500. Over the past 52 weeks, CNTA has reached a high of $19.09, while it has fallen to a 52-week low of $7.75. The 50-Day Moving Average of the stock is -25.97%, while the 200-Day Moving Average is calculated to be -21.86%.
Shares Statistics:
According to the various share statistics, CNTA traded on average about 1.00M shares per day over the past 3-months and 1370040 shares per day over the past 10 days. A total of 132.63M shares are outstanding, with a floating share count of 84.29M. Insiders hold about 36.45% of the company’s shares, while institutions hold 54.85% stake in the company. Shares short for CNTA as of 1743379200 were 4375416 with a Short Ratio of 4.35, compared to 1740700800 on 5458260. Therefore, it implies a Short% of Shares Outstanding of 4375416 and a Short% of Float of 3.88.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
